Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.65−2.70 (-20.22%)
Close on Nov 12, 2026Market cap $275.20MP/E –Yield –
Faeth Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Faeth Therapeutics's enterprise value was $158.43M on Nov 11, 2026, against -$14.42M a year earlier. Over the last 5 years it ranged from -$174.46M to $660.11M, with a median of -$40.23M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $158.43M | – |
| 2025 | Dec 31, 2025 | -$11.58M | – |
| 2024 | Dec 31, 2024 | -$34.67M | – |
| 2023 | Dec 29, 2023 | -$54.72M | – |
| 2022 | Dec 30, 2022 | -$70.78M | -441.1% |
| 2021 | Dec 31, 2021 | $20.75M | – |
See a number that looks wrong?